Päivi Äänismaa

Suggest Changes
Learn More
AIMS This study investigated the effect of a fixed dose combination of lopinavir/ritonavir on the pharmacokinetics (PK) of selexipag and its active metabolite ACT-333679. METHODS This was an open(More)
  • 1